Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.86 -0.09 (-4.62%)
As of: Nov 10, 2026 · 1:25 PM EST

Processa Pharmaceuticals (PCSA) Receivables - Net (2012 - 2018)

Updated

Analysis

Processa Pharmaceuticals (PCSA) Receivables - Net (2012 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Processa Pharmaceuticals 5.21 Mn -8.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 107,490.00
Sep 30, 2015 11,613.00
Jun 30, 2015 15,060.00
Mar 31, 2015 5,150.00
Dec 31, 2014 1,310.00
Sep 30, 2014 26,739.00
Jun 30, 2014 99,030.00
Mar 31, 2014 20,345.00
Dec 31, 2013 19,200.00
Sep 30, 2013 24,399.00
Jun 30, 2013 61,154.00
Dec 31, 2012 30,451.00
API Access

Processa Pharmaceuticals Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=PCSA&period=max&api_key=YOUR_API_KEY